NPs Basic Information

Name
Trichodermol
Molecular Formula C15H22O3
IUPAC Name*
(1S,2R,7R,9R,11R,12S)-1,2,5-trimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-ol
SMILES
CC1=C[C@@H]2[C@](CC1)([C@]3([C@@H](C[C@H]([C@@]34CO4)O2)O)C)C
InChI
InChI=1S/C15H22O3/c1-9-4-5-13(2)11(6-9)18-12-7-10(16)14(13,3)15(12)8-17-15/h6,10-12,16H,4-5,7-8H2,1-3H3/t10-,11-,12-,13+,14-,15+/m1/s1
InChIKey
XSUVNTHNQMGPIL-LACSLYJWSA-N
Synonyms
Trichodermol; Roridin C; 2198-93-8; 709J50QEIQ; (2S,2'R,4'R,5'S,5a'R,9a'R)-5',5a',8'-trimethyl-2',3',4',5',5a',6',7',9a'-octahydrospiro[oxirane-2,10'-[2,5]methanobenzo[b]oxepin]-4'-ol; TRICHODERMOL [MI]; UNII-709J50QEIQ; CHEMBL2047177; BRN 1287601; 12,13-Epoxytrichothec-9-en-4-beta-ol; Trichothec-9-en-4-beta-ol, 12,13-epoxy-; (4-beta)-12,13-Epoxytrichothec-9-en-4-ol; 4.BETA.-HYDROXY-12,13-EPOXYTRICHOTHEC-9-ENE; Q26840798; Trichothec-9-en-4-ol, 12,13-epoxy-, (4-beta)-; TRICHOTHEC-9-EN-4-OL, 12,13-EPOXY-, (4.BETA.)-; (1S,2R,7R,9R,11R,12S)-1,2,5-trimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-ol
CAS 2198-93-8
PubChem CID 12315016
ChEMBL ID CHEMBL2047177
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Sesquiterpenoids
          • Direct Parent: Trichothecenes

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 250.33 ALogp: 1.2
HBD: 1 HBA: 3
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 42.0 Aromatic Rings: 4
Heavy Atoms: 18 QED Weighted: 0.531

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.815 MDCK Permeability: 0.00001490
Pgp-inhibitor: 0 Pgp-substrate: 0.374
Human Intestinal Absorption (HIA): 0.005 20% Bioavailability (F20%): 0.006
30% Bioavailability (F30%): 0.011

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.237 Plasma Protein Binding (PPB): 64.36%
Volume Distribution (VD): 1.753 Fu: 27.48%

ADMET: Metabolism

CYP1A2-inhibitor: 0.059 CYP1A2-substrate: 0.551
CYP2C19-inhibitor: 0.162 CYP2C19-substrate: 0.839
CYP2C9-inhibitor: 0.062 CYP2C9-substrate: 0.072
CYP2D6-inhibitor: 0.007 CYP2D6-substrate: 0.154
CYP3A4-inhibitor: 0.156 CYP3A4-substrate: 0.376

ADMET: Excretion

Clearance (CL): 6.101 Half-life (T1/2): 0.429

ADMET: Toxicity

hERG Blockers: 0.044 Human Hepatotoxicity (H-HT): 0.775
Drug-inuced Liver Injury (DILI): 0.164 AMES Toxicity: 0.866
Rat Oral Acute Toxicity: 0.292 Maximum Recommended Daily Dose: 0.453
Skin Sensitization: 0.457 Carcinogencity: 0.125
Eye Corrosion: 0.024 Eye Irritation: 0.523
Respiratory Toxicity: 0.906
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003277 0.683 D06IIB 0.255
ENC001879 0.607 D0L2LS 0.253
ENC005756 0.557 D04GJN 0.245
ENC006152 0.440 D0Y2YP 0.243
ENC001856 0.424 D0Y7IU 0.239
ENC004000 0.423 D04QNO 0.239
ENC004001 0.380 D0Z1XD 0.236
ENC004774 0.367 D0U3GL 0.236
ENC002696 0.351 D02JNM 0.236
ENC003173 0.351 D0P0HT 0.235
*Note: the compound similarity was calculated by RDKIT.